HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of prophylactic mebendazole in experimental peritoneal hydatidosis.

Abstract
The primary treatment of hydatid disease is surgical. The most important complication of the surgical treatment is secondary hydatidosis due to spillage of the cyst contents. Medical treatment, with mebendazole, has been used extensively. This study was undertaken to evaluate the prophylactic effect of mebendazole in experimental peritoneal hydatidosis. Mebendazole was given for 96 hours in a dose of 40 to 65 milligrams per kilogram per day before the inoculation of scolices intraperitoneally. This prophylactic therapy decreased the intraperitoneal formation of cysts significantly from 80 to 11 per cent (p less than 0.005). The preoperative administration is recommended to prevent secondary hydatidosis due to spillage of scolices during the operative intervention.
AuthorsI Sayek, M Cakmakçi
JournalSurgery, gynecology & obstetrics (Surg Gynecol Obstet) Vol. 163 Issue 4 Pg. 351-3 (Oct 1986) ISSN: 0039-6087 [Print] United States
PMID3764639 (Publication Type: Journal Article)
Chemical References
  • Mebendazole
Topics
  • Animals
  • Echinococcosis (prevention & control, surgery)
  • Female
  • Male
  • Mebendazole (therapeutic use)
  • Mice
  • Peritoneal Diseases (prevention & control)
  • Postoperative Complications (prevention & control)
  • Preoperative Care

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: